Published in Gene Therapy Weekly, August 21st, 2003
Using diagnostic ultrasound (US) images, Douglas Miller and colleagues applied HIFU at 1.55 MHz to renal carcinoma tumors implanted in the hind leg of BALB/c mice. "One test of transfection was also performed with lithotripter shock waves," they said.
"In one set of exposures, tumor volume was followed for 4 days and a beta-galactosidase marker plasmid was used for localization of transfected cells. A second set of exposures employed a luciferase marker plasmid for...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.